+- OMMP Pay if Forward (https://www.ommppayitforward.com)
+-- Forum: Conditions alleviated with cannabis (https://www.ommppayitforward.com/forumdisplay.php?fid=26)
+--- Forum: Conditions alleviated with cannabis (https://www.ommppayitforward.com/forumdisplay.php?fid=145)
+--- Thread: Zynerba Pharma Wins Big on Cannabis Trial (/showthread.php?tid=3433)
Zynerba Pharma Wins Big on Cannabis Trial - Purple Power - 09-28-2017
Zynerba Pharma Wins Big on CannabisTrial
<p class="post-meta">
By <a class="vcard author url" href="http://247wallst.com/author/chris-lange/" itemprop="author" itemscope="" itemtype="http://schema.org/Person" title="Posts by Chris Lange"><span class="fn" itemprop="name">Chris Lange</a></span> September 28, 2017
Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) shares saw a huge gain early on Thursday after the firm announced positive results from its mid-stage cannabinoid trial. Specifically, the firm was evaluating ZYN002 cannabidiol (CBD) gel in pediatric and adolescent patients with fragile X syndrome (FXS).
For some quick background: fragile X syndrome is an autism spectrum disorder affecting one in 4,000 males and one in 8,000 females. It is the most common inherited intellectual disability in males and a significant cause of intellectual disability in females.
http://247wallst.com/healthcare-business/2017/09/28/zynerba-pharma-wins-big-on-cannabis-trial/